TECHNICAL TRANSFER AGREEMENTTechnical Transfer Agreement • October 21st, 2010 • Horizon Pharma, Inc. • Pharmaceutical preparations • New York
This Technical Transfer Agreement (together with the Schedules hereto, this “Agreement”) is entered into as of November 9, 2009 (the “Effective Date”)
CONFIDENTIAL TREATMENT REQUESTED. CONFIDENTIAL PORTIONS OF THIS DOCUMENT HAVE BEEN REDACTED AND HAVE BEEN SEPARATELY FILED WITH THE COMMISSION.*** TECHNICAL TRANSFER AGREEMENTTechnical Transfer Agreement • November 23rd, 2005 • Inyx Inc • Pharmaceutical preparations • New York
THIS TECHNICAL TRANSFER AGREEMENT is made and entered into this 8th day of September, 2005 (the “Effective Date”), by and between INYX, INC., having an address at 825 Third Avenue, 40th Floor, New York, New York 10022 (“Inyx”) and KING PHARMACEUTICALS, INC., having an address at 501 Fifth Street, Bristol, Tennessee 37620 (“King”) (each individually a “Party” and collectively the “Parties”).
